Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 13 (7), 1469-1476
- https://doi.org/10.1016/0735-1097(89)90334-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: Improved timing, thrombolytic efficacy and ventricular functionJournal of the American College of Cardiology, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.Circulation, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Serial measurements of left ventricular ejection fraction by radionuclide angiography early and late after myocardial infarctionThe American Journal of Cardiology, 1976
- Left Ventricular Function in Acute Myocardial Infarction Evaluated by Gated ScintiphotographyCirculation, 1974
- Estimation of Infarct Size in Man and its Relation to PrognosisCirculation, 1972